Evidence map›Paper›PMID 25732414›Full record

ArticleThe American journal of gastroenterology2015

How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?

Alain M Schoepfer, Radoslaw Panczak, Marcel Zwahlen, Claudia E Kuehni, Michael Coslovsky, Elisabeth Maurer, Nadine A Haas, Jeffrey A Alexander, Evan S Dellon, Nirmala Gonsalves and 20 more

Abstract read
PubMed Publisher
In one paragraph

Article in The American journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Endoscopic response to topical steroids is associated with a need for fewer future esophageal dilations.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. What patients with eosinophilic esophagitis may not share with their providers: a qualitative assessment of online health communities.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2019
    Review
  12. Eosinophilic esophagitis: pathophysiology and its clinical implications.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Review
  13. Review
  14. Article
  15. Article
  16. Eosinophilic esophagitis: What can we learn from Crohn's disease?United European gastroenterology journal · 2017
    Review
  17. White Paper AGA: Drug Development for Eosinophilic Esophagitis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2017
    Review
  18. Article
  19. How I Approach the Management of Eosinophilic Esophagitis in Adults.The American journal of gastroenterology · 2017
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Alain M SchoepferDivision of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois/CHUV, Lausanne, Switzerland.
Radoslaw PanczakInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Marcel ZwahlenInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Claudia E KuehniInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Michael Coslovsky1] Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland [2] Clinical Trials Unit Bern, Department of Clinical Research, University of Bern, Bern, Switzerland.
Elisabeth MaurerInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Nadine A HaasInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Jeffrey A AlexanderDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Evan S DellonDivision of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Nirmala GonsalvesDivision of Gastroenterology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Ikuo HiranoDivision of Gastroenterology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
John LeungFood Allergy Center at Tufts Medical Center and Floating Hospital for Children, Division of Allergy and Immunology, Division of Gastroenterology and Hepatology, Tufts Medical Center, Boston, Massachusetts, USA.
Christian BussmannViollier AG, Basel, Switzerland.
Margaret H CollinsDivision of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Robert O NewburyDepartment of Pathology, Rady Children's Hospital, University of California, San Diego, San Diego, California, USA.
Giovanni De PetrisDepartment of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Scottsdale, Arizona, USA.
Thomas C SmyrkDepartment of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
John T WoosleyDepartment of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Pu YanInstitut Universitaire de Pathologie de Lausanne, Lausanne, Switzerland.
Guang-Yu YangDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Yvonne Romero1] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA [2] Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA [3] GI Outcomes Unit, Mayo Clinic, Rochester, Minnesota, USA.
David A KatzkaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Glenn T FurutaDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Sandeep K GuptaDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Riley Hospital for Children and Indiana University School of Medicine, Indianapolis, Indiana, USA.
Seema S AcevesDivision of Allergy and Immunology, Rady Children's Hospital, University of California, San Diego, San Diego, California, USA.
Mirna ChehadeDepartments of Pediatrics and Medicine, Mount Sinai Center for Eosinophilic Disorders, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Carine BlanchardAllergy Group, Nutrition and Health Research, Nestlé Research Center, Lausanne, Switzerland.
Alex Straumann1] Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland [2] Swiss EoE Research Group, Praxis Römerhof, Olten, Switzerland.
Ekaterina SafroneevaInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
International EEsAI Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThere is no "gold standard" for assessing disease activity in patients with eosinophilic esophagitis (EoE). We aimed to compare physicians' judgment of EoE activity with patients' judgment of symptom severity. We also aimed to examine the relative contribution of symptoms as well as endoscopic and histologic findings in shaping physicians' judgment of EoE activity.

methodsSix gastroenterologists (all EoE experts) assessed EoE-associated symptoms in adult patients. Patients completed a symptom instrument and provided global assessment of EoE symptom severity (PatGA) (Likert scale: 0 (inactive) to 10 (most active)). Following esophagogastroduodenoscopy with biopsy sampling, gastroenterologists provided a global assessment of EoE activity (PhysGA) (Likert scale from 0 to 10) based on patient history and endoscopic and histologic findings. Linear regression and analysis of variance was used to quantify the extent to which variations in severity of EoE symptoms and endoscopic and histologic findings explain variations in PhysGA.

resultsA total of 149 EoE patients were prospectively included (71.8% male, median age at inclusion 38 years, 71.8% with concomitant allergies). A moderate positive correlation between PhysGA and PatGA (rho=0.442, P<0.001) was observed and the mean difference in the Bland-Altman plot was 1.77. Variations in severity of endoscopic findings, symptoms, and histologic findings alone explained 53%, 49%, and 30%, of the variability in PhysGA, respectively. Together, these findings explained 75% of variability in PhysGA.

conclusionsGastroenterologists rate EoE activity mainly on the basis of endoscopic findings and symptoms and, to a lesser extent, on histologic findings.

Indexed as

Medical History TakingPractice Patterns, Physicians'Symptom AssessmentAdultAnalysis of VarianceDiagnostic Self EvaluationEndoscopy, Digestive SystemEosinophilic EsophagitisEsophagusFemaleHumansHypersensitivityImage-Guided BiopsyMaleMiddle AgedPatient Acuity

Identifiers

PMID25732414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.